Pregabalin is a second-generation anticonvulsant and neuropathic pain agent belonging to the gabapentinoid class. It works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P.
By modulating calcium channel activity, Pregabalin reduces abnormal nerve signal transmission. This results in reduced pain perception (analgesic effect), calmer neural firing (anti-seizure effect), and lower anxiety-related neurotransmitter levels — making it effective across multiple therapeutic areas.
Our Pregabalin 50 mg capsules are manufactured in WHO-GMP certified facilities with strict in-process quality controls. Each batch undergoes HPLC-based assay testing, dissolution profiling, and content uniformity checks to ensure consistent therapeutic outcomes and full regulatory compliance for both domestic and export markets.
Initial dose: 75 mg twice daily or 50 mg three times daily (150 mg/day). May be increased to 300 mg/day after one week based on response and tolerability. Maximum recommended dose: 600 mg/day in 2–3 divided doses.
Initial dose: 50 mg three times daily (150 mg/day). Can be titrated to 300 mg/day after one week, and further to 600 mg/day if required. Always used in combination with other antiepileptic drugs as per physician guidance.
Starting dose: 150 mg/day in 2–3 divided doses. Dose may be increased to 300–600 mg/day based on individual response. Taper dose gradually when discontinuing — do not stop abruptly.
* All dosages are indicative and for reference only. Actual prescription depends on physician assessment. Dose adjustment required in renal impairment (adjust based on creatinine clearance).
| Composition | Pregabalin IP 50 mg |
|---|---|
| Dosage Form | Hard Gelatin Capsules |
| Strength | 50 mg per capsule |
| Packaging | 10×10 Alu-Alu Blister Pack |
| Therapeutic Category | Neuropathic Pain / Anticonvulsant / Anxiolytic |
| Drug Class | Gabapentinoid (Alpha-2-Delta Ligand) |
| Drug Schedule | Schedule H (Prescription Only) |
| Pharmacopoeia Standard | IP / USP |
| Manufacturing Standard | WHO-GMP Certified |
| Available Strengths | 50 mg, 75 mg, 150 mg, 300 mg |
| Minimum Order Qty | 1,000 Units / 100 Strips |
| Country of Origin | India |
Like all medicines, Pregabalin may cause side effects. Below are commonly reported adverse reactions. Not all patients experience them, and severity varies with dose.
Store below 30°C in a cool, dry place. Avoid exposure to excessive heat or direct sunlight.
Protect from moisture. Keep in original Alu-Alu blister packaging until point of use. Do not store in bathrooms.
24–36 months from the date of manufacturing. Packed in 10×10 Alu-Alu blister strips, enclosed in printed outer cartons.
Shipped via temperature-monitored logistics (cold chain not required for this product). Complete export documentation including COA, MSDS, GMP Certificate, and Free Sale Certificate available on request.
